8539 related articles for article (PubMed ID: 22590832)
1. AT1 receptors activation enhances the expression of MMP-2, MMP-13 and VEGF but not MMP-9 in B16F10 melanoma cells.
Akhavan MM; Karimi M; Ghodrati M; Falahtpishe H
Pak J Biol Sci; 2011 Sep; 14(17):821-30. PubMed ID: 22590832
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II evokes angiogenic signals within skeletal muscle through co-ordinated effects on skeletal myocytes and endothelial cells.
Gorman JL; Liu ST; Slopack D; Shariati K; Hasanee A; Olenich S; Olfert IM; Haas TL
PLoS One; 2014; 9(1):e85537. PubMed ID: 24416421
[TBL] [Abstract][Full Text] [Related]
3. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB.
Nadal JA; Scicli GM; Carbini LA; Scicli AG
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H739-48. PubMed ID: 11788425
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts.
Nakai K; Kawato T; Morita T; Iinuma T; Kamio N; Zhao N; Maeno M
Biochimie; 2013 Apr; 95(4):922-33. PubMed ID: 23277113
[TBL] [Abstract][Full Text] [Related]
6. Interaction between sympathetic nervous system and renin angiotensin system on MMPs expression in juvenile rat aorta.
Dab H; Hachani R; Hodroj W; Sakly M; Bricca G; Kacem K
Gen Physiol Biophys; 2011 Sep; 30(3):271-7. PubMed ID: 21952436
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis.
Peng J; Gurantz D; Tran V; Cowling RT; Greenberg BH
Circ Res; 2002 Dec; 91(12):1119-26. PubMed ID: 12480812
[TBL] [Abstract][Full Text] [Related]
8. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells.
Papakonstantinou E; Roth M; Kokkas B; Papadopoulos C; Karakiulakis G
J Cardiovasc Pharmacol; 2001 Nov; 38(5):715-28. PubMed ID: 11602818
[TBL] [Abstract][Full Text] [Related]
9. Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells.
Guo YS; Wu ZG; Yang JK; Chen XJ
Mol Med Rep; 2015 Mar; 11(3):1587-94. PubMed ID: 25405958
[TBL] [Abstract][Full Text] [Related]
10. Losartan inhibited expression of matrix metalloproteinases in rat atherosclerotic lesions and angiotensin II-stimulated macrophages.
Liang C; Wu ZG; Ding J; Jiang JF; Huang GZ; Du RZ; Ge JB
Acta Pharmacol Sin; 2004 Nov; 25(11):1426-32. PubMed ID: 15525463
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities.
Stacy LB; Yu Q; Horak K; Larson DF
Perfusion; 2007 Jan; 22(1):51-5. PubMed ID: 17633135
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols.
Walter A; Etienne-Selloum N; Sarr M; Kane MO; Beretz A; Schini-Kerth VB
J Vasc Res; 2008; 45(5):386-94. PubMed ID: 18354258
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
15. Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.
Hua C; Zhao G; Feng Y; Yuan H; Song H; Bie L
J Neurotrauma; 2016 Jan; 33(1):65-70. PubMed ID: 25646653
[TBL] [Abstract][Full Text] [Related]
16. Losartan impairs HTR-8/SVneo trophoblast migration through inhibition of angiotensin II-induced pro-inflammatory profile in human endometrial stromal cells.
Macchi R; Sotelo AD; Parrado AC; Salaverry LS; Blanco GA; Castro MS; Rey-Roldán EB; Canellada AM
Toxicol Appl Pharmacol; 2023 Feb; 461():116383. PubMed ID: 36682589
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
Guo RW; Yang LX; Wang H; Liu B; Wang L
Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
[TBL] [Abstract][Full Text] [Related]
18. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma.
Otake AH; Mattar AL; Freitas HC; Machado CM; Nonogaki S; Fujihara CK; Zatz R; Chammas R
Cancer Chemother Pharmacol; 2010 May; 66(1):79-87. PubMed ID: 19771429
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II on STAT3 mediated atrial structural remodeling.
Zheng LY; Zhang MH; Xue JH; Li Y; Nan Y; Li MJ; Wang J; Du XP
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2365-77. PubMed ID: 25219839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
